Apple Watches Don’t Fall Under Limited Exclusion Order For ECG Tech

US Customs and Border Protection ruled that Apple’s ECG technology doesn’t infringe on AliveCor’s patent and doesn’t have to comply with a previous import ban.

• Source: Shutterstock

Tech giant Apple has cinched another win in its ongoing electrocardiogram (ECG) patent case against AliveCor. US Customs and Border Protection ruled in June that Apple’s EXG technology doesn’t infringe on AliveCor’s patent, meaning that it doesn’t need to pay a fee of $2 per watch to import them.

The US International Trade Commission (ITC) previously ruled that Apple had infringed on AliveCor’s ECG patents, which set the import...

More from Regulation

More from Policy & Regulation

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By 

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.